Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT02076412
Status:
COMPLETED
Last Update Posted:
2019-01-25
First Post:
2014-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Sponsor:
Rigel Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-26
First Submit QC Date:
None
Study First Post Date:
2014-03-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-16
Results First Submit QC Date:
None
Results First Post Date:
2019-01-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-08-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2019-01-24
Last Update Post Date:
2019-01-25
Last Update Post Date Type:
ACTUAL